Minerals 260 Stock Quote MI6 - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.16

Bid

0.155

Ask

0.16

Volume

8,090

0.16 Day's Range 0.16

0.115 52 Week Range 0.64

Market Cap

37.44M

Previous Close

0.16

Open

0.16

Last Trade

8090

0.16

Last Trade Time

20:04:16

Financial Volume

VWAP

Average Volume (3m)

180,023

Shares Outstanding

234,000,000

Dividend Yield

PE Ratio

-2.86

Earnings Per Share (EPS)

-0.06

Revenue

Net Profit

-13.11M

Sector

Metal Mining Services

Industry

Metal Mining Services

Website

www.minerals260.com.au

Headquarters

Perth, Western Australia, Aus

Founded

1970

Minerals 260 Ltd is listed in the Metal Mining Services sector of the Australian Stock Exchange with ticker MI6. The last closing price for Minerals 260 was AUD0.16. Over the last year, Minerals 260 shares have traded in a share price range of AUD 0.115 to AUD 0.64.

Minerals 260 currently has 234,000,000 shares outstanding. The market capitalization of Minerals 260 is AUD37.44 million. Minerals 260 has a price to earnings ratio (PE ratio) of -2.86.

ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results

PLEASANTON, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy™ for the treatment of Obstructive Sleep Apnea (OSA), today announced financial...

Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks

In Monday’s pre-market trading, U.S. index futures are mixed, with Wall Street in anticipation of the monetary policy guidelines that the Federal Reserve is expected to release during the...

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today it has...

ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea

PLEASANTON, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced results of its pilot...

ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024

PLEASANTON, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy for the treatment of Obstructive Sleep Apnea (OSA), announced today that it will...

ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA

PLEASANTON, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today that the United...

ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices

PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that the company is...

ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea

PLEASANTON, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, welcomes the adoption of...

Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices

PLEASANTON, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, today announced the publication...

ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results

PLEASANTON, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), the leading non-CPAP Obstructive Sleep Apnea Therapy, today announced financial results for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.025	18.5185185185	0.135	0.16	0.135	288942	0.15430942	DE
4	0.02	14.2857142857	0.14	0.16	0.13	165339	0.14982156	DE
12	0.015	10.3448275862	0.145	0.205	0.115	180023	0.14902951	DE
26	-0.025	-13.5135135135	0.185	0.205	0.115	156700	0.15306384	DE
52	-0.47	-74.6031746032	0.63	0.64	0.115	185305	0.29998163	DE
156	-0.585	-78.5234899329	0.745	0.845	0.115	344347	0.46351191	DE
260	-0.585	-78.5234899329	0.745	0.845	0.115	344347	0.46351191	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AHNOAthena Resources Ltd	AUD 0.002 (100.00%)	2.5M
AD1AD1 Holdings Limited	AUD 0.01 (66.67%)	101.96k
A1GAfrican Gold Limited	AUD 0.04 (66.67%)	7M
APCAustralian Potash Limited	AUD 0.0015 (50.00%)	517.86k
R8RRegener8 Resources NL	AUD 0.135 (37.76%)	103.01k
ERAEnergy Resources Of Australia Limited	AUD 0.025 (-28.57%)	1.87M
LM1Leeuwin Metals Ltd	AUD 0.06 (-28.57%)	37.12k
M2ROAMiramar Resources Limited	AUD 0.0015 (-25.00%)	4M
ADOOAnteoTech Limited	AUD 0.006 (-25.00%)	2.33M
IVXInvion Ltd	AUD 0.003 (-25.00%)	184.2k
TEGTriangle Energy Global Limited	AUD 0.014 (-17.65%)	20.01M
TRITrivarX Ltd	AUD 0.041 (10.81%)	10.9M
OSLOOncoSil Medical Ltd	AUD 0.002 (0.00%)	10.84M
OSLOncosil Medical Ltd	AUD 0.0125 (13.64%)	10.83M
ADOAnteoTech Limited	AUD 0.022 (4.76%)	10.5M